Home
Tests sections
4276. Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

All test sections

TOP tests

What to check

For whom

Check-up

Biomaterial

4276. Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

Turnaround time (days): 2

740 ₴

Important information

* TEST FOR WOMEN ONLY

* During the order process, the operator confirms the day of the menstrual cycle or pregnancy term

* The test can only be performed with a special referral from a doctor* Sample collection is not performed for minors (under 18) or pregnant women at collection sites (only pre-collected samples are accepted)

Description

The Pap test using the BD SurePath™ liquid-based cytology method is a modern and highly accurate screening tool for the early detection of cervical cancer and precancerous lesions.

At Synevo, the examination is performed using a dual-review approach:

the expertise of experienced cytologists;
the BD FocalPoint™ GS Imaging System (Becton Dickinson, USA) – a digital microscopy system powered by artificial intelligence – combined with the ZEISS Axioscope 5 microscope (Carl Zeiss, Germany).

This approach significantly increases the sensitivity and reliability of detecting pathological changes. The test helps identify cervical epithelial cells with precancerous or malignant transformations at the earliest stages – when treatment is most effective.

In Ukraine, cervical cancer ranks among the top three most common oncological diseases in women. According to the Order of the Ministry of Health of Ukraine No. 1057 dated June 18, 2024, women aged 21-65 years are recommended to undergo cytological screening every 3 years, or HPV testing with genotyping every 5 years between the ages of 30-65 years.

When and who needs the test?

Routine screening and diagnosis of precancerous cervical lesions
Following an abnormal HPV test result
After treatment of CIN and/or conization
In cases of detected dysplasia or inflammatory changes
In the presence of sexually transmitted infections (STIs)
Monitoring the effectiveness of cervical pathology treatment

Biological material

Site-specific scrapings collected depending on the test

Preparation for cytology

Collect the material before starting treatment with antibacterial/antifungal drugs (general and local action).
In case of treatment monitoring – 14 days after the end of the course of treatment with antibacterial/antifungal drugs.
Avoid sexual intercourse for 3 days.
Exclude douching and the use of vaginal...

Cheaper in a package

4277. Package #129 (Cervical screening: PAP test using liquid cytology (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved), PCR. HPV HCR 14 genotypes, quantitative determination)

Number of tests: 2

Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

PCR. HPV HCR (quantification CS)

Turnaround time (days): 3

1650 ₴

4279. Package #151 (Cervical screening with p16 and Ki-67: PAP test using liquid cytology (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved), PCR. HPV HCR 14 genotypes, quantitative determination, p16, Ki-67

Number of tests: 3

Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

PCR. HPV HCR (quantification CS)

Proliferation markers p16 and Ki-67

Turnaround time (days): 3

3210 ₴

4282. Package #129.6 (Cervical screening extended: PAP test using liquid cytology (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved), p16 and Ki-67 markers, Capsid test)

Number of tests: 3

Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

Capsid test (protein HPV L1)

Proliferation markers p16 and Ki-67

Turnaround time (days): 4

4420 ₴

4280. Package # 678.1 (Cervical pathology screening: PAP test using liquid cytology (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved), PCR. HPV 28 (genotyping, qualitative determination), PCR. Screening 7 STI)

Number of tests: 3

Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

PCR. HPV 28 (genotyping 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 69, 73, 82, 6, 11, 40, 42, 43, 44, 54, 61, 70, U/G scraping, qualitative determination)

PCR. Screening of 7 STI: Ch.trachomatis, N.gonorrhoeae, M.genitalium, M.hominis, U.urealyticum, U.parvum, Tr.vaginalis

Turnaround time (days): 3

2490 ₴

4281. Package #129.5 (Cervical screening with capsid test: PAP test by liquid cytology method (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved), Capsid test)

Number of tests: 2

Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

Capsid test (protein HPV L1)

Turnaround time (days): 4

2720 ₴

4285. Package # 250 (Cervical screening, COTESTING: Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved) and PCR. HPV HCR 14 (cobas HPV FDA approved).

Number of tests: 2

Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

PCR. HPV HCR 14 (cobas HPV FDA approved). Genotyping 16 and 18 and groups 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 (u/g scrape, qualitative)

Turnaround time (days): 3

1500 ₴

4276. Liquid-based cytology PAP test (BD SurePath technology, FDA approved). CYTOLOGICAL PASSPORT (BD FocalPoint technology, FDA approved).

740 ₴